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Abstract
Background: Psoriasis is a frequent skin inflammatory disorder that inflicts millions of patients around the globe. To
meet their healthcare needs, patients with psoriasis often seek treatment outside the allopathic paradigm. Use of
medicinal plants has emerged as one of the most common and preferred modalities of complementary and
alternative medicine (CAM). The aim of this study was to investigate the use of medicinal plants by patients with
psoriasis in the West Bank of Palestine.
Methods: The current study was a questionnaire based cross-sectional descriptive study on the use of medicinal
plants by psoriasis patients in the West Bank of Palestine. A sample of 149 patients with psoriasis who were visiting
outpatient clinics responded to the questionnaire in face to face interviews.
Results: Medicinal plants were used by 81 (54.4%) patients with psoriasis. Patients used 33 medicinal plants
belonging to 26 families. Plants belonging to Lamiaceae and Leguminosae were the most commonly used by the
study patients. Aloe vera, Trigonella arabica, Catharanthus roseus and Anthemis cotula were the most frequently used
medicinal plants to treat psoriasis. Leaves and fruits were the most commonly used parts by the study patients.
Paste was the most commonly used form of preparation. The use of medicinal plants was significantly associated
with age and monthly household income of the patients. Enhancement of immunity, improving conventional
therapy and reduction of side effects were the most commonly self-reported reasons for using medicinal plants.
Conclusions: Patients with psoriasis in Palestine seem to use medicinal plants as a CAM modality to manage their
psoriasis. Many medicinal plants were commonly used by patients with psoriasis. More randomized clinical trials are
needed to demonstrate safety and efficacy for the majority of these medicinal plants reported to be used by
patients with psoriasis in Palestine.
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Background
Psoriasis is a frequent skin inflammatory disorder that
inflicts approximately 2–3% of the populations around
the globe [1, 2]. However, prevalence of psoriasis varies
across geographical locations and races. Research con-
ducted in the Middle East showed that the incidence of
psoriasis in Algeria, Tunisia and Morocco was estimated
at 10.36, 13.26 and 15.04 per 1000, respectively [3]. The
severity of psoriasis varies from scattered papules to gen-
eralized scaly plaques [4]. Depending on location and
severity of lesions, psoriasis might have negative conse-
quences on the quality of life of the patients in terms of
physical and emotional well-being [4].
Management of psoriasis largely depends on the
severity and location of lesions. Systemic therapy, photo-
therapy and agents applied topically have emerged as
therapeutic options in the management of psoriasis [5].
Retinoids, cyclosporine, methotrexate and biologics are
approved by the US Food and Drug Administration
(FDA) for systemic therapy of psoriasis [6]. The
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American Academy of Dermatology recommends the
use of systemic therapy and phototherapy for sever
lesions. Agents applied topically are recommended for
mild and localized lesions that do not affect the daily
activities of the patient [5]. However, previous studies have
shown that systemic therapy and phototherapy are under-
used because patients prefer topical preparations [7, 8].
Recent statistics showed that only 43% of patients diag-
nosed with severe psoriasis received systemic therapy [8].
Poor patient adherence and physician reluctance to
prescribe systemic treatments were associated with many
factors including adverse effects, intolerance, affordability
and development of resistance to therapies [1, 9–11].
Published therapeutic guidelines for the management
of psoriasis do not fully satisfy the expectations of
patients. Moreover, patients with psoriasis experience
inevitable avoidance behavior and psychological distur-
bances that deteriorate their quality of life [1, 12]. Not
surprisingly, patients with psoriasis often seek treat-
ments outside the allopathic paradigm to meet their
healthcare needs considering the chronic and frustrating
nature of the disease [13–15]. Patients with psoriasis
were shown to use different modalities of complemen-
tary and alternative medicine (CAM) [14, 16]. The use
of medicinal plants has evolved as one of the most pre-
ferred CAM modalities across different cultures around
the globe [13]. Some medicinal plants are used topically
while others are ingested for systemic effects. We believe
that healthcare professionals should be aware that
patients might be using such medicinal plants as an alter-
native to or in combination with allopathic treatments.
The use of medicinal plants has long been regarded as
non-evidence based practice [17]. Today, leading
academic and regulatory institutions are setting stan-
dards to encourage conducting randomized clinical trials
using different CAM modalities including the use of me-
dicinal plants in a scientifically rigorous fashion [18, 19].
A considerable number of randomized controlled
clinical trials have been conducted using different medi-
cinal plants to treat signs/symptoms of psoriasis [15].
Some medicinal plants were shown to improve signs and
symptoms of psoriasis while other did not shown any
significant improvements [14, 15, 17].
As using medicinal plants is based on centuries old tradi-
tions, their patterns of use differ from culture to another.
Globally, little is known on the association of different
sociodemographic factors like age, gender, educational and
economic status with the pattern of use of medicinal plants
to treat psoriasis. In Palestine, little is known on the use of
medicinal plants by patients with psoriasis. The present
study was conducted to investigate the pattern of use of
medicinal plants among psoriasis patients in Palestine, to
assess clinical and sociodemographic predictors of using
medicinal plants and to identify perceived benefits from
using medicinal plants by patients with psoriasis. The study
also aims to identify the sources of information and the
underlying reasons for using medicinal plants to treat psor-
iasis. This study was conducted with special emphasis on
the use of medicinal plants as a CAM modality.
Methods
The present study was undertaken in a cross-sectional
observational design at outpatient clinics all over the
West Bank of Palestine. A convenient sample was
recruited from outpatient clinics in the period of August
2015 to December 2015.
Structured interview and validation of the questionnaire
The method used in this study was based on our previ-
ously published study [13]. Briefly, ten psoriasis patients
were interviewed in the first stage of the study to
explore their views on the use of medicinal plants to
treat their psoriasis and the methods they use in the
preparation of these medicinal plants.
A questionnaire containing two sections was devel-
oped as in our previous study [13]. In the first section,
patients were requested to provide their sociodemo-
graphic details such as age, educational status, marital
status, place of residence, monthly household income,
disease stage, period relapsed since the patient was diag-
nosed with the disease, type of treatments used, whether
the patient used medicinal plants or not (Additional file 1).
Inclusion of these sociodemographic variables was based
on a literature review of previous studies. In the second
section, patients were requested to answer open-ended
questions to provide the names of medicinal plants used,
reasons why the patient used these medicinal plants, who
informed the patient about these medicinal plants,
methods of preparing medicinal plants and the sources of
these medicinal plants.
The questionnaire was piloted and revised to help un-
derstanding. Two trained researchers conducted the
interviews and collected the questionnaires from the
study participants.
Statistical analysis
For statistical analysis, patients recruited for this study
were categorized as either users of medicinal plants or
nonusers based on whether they used medicinal plants
or not in the last 6 months. Some data pertaining to
period relapsed since the patient was diagnosed with the
disease, disease stage and previous treatments were
obtained from the medical records of the patients. Pear-
son’s Chi-Square (χ2) or Fisher’s Exact Tests were used
to compare categorical groups, as appropriate. Spear-
man’s rank correlation was used to correlate categorical
data. Statistical significance was considered when the p
value was less than 0.05. Data were processed using IBM
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SPSS for Windows v.21.0 (IBM-SPSS, Chicago, Illinois,
USA). In this analysis, users of medicinal plants were
considered equally without regard to the number of
medicinal plants they used.
Ethical approval
The protocol and ethics of the present study were
approved by the Institutional Review Board (IRB) of
An-Najah National University (protocol No. 62/Aug/
2015). Participants signed an informed consent before
they took part in the present study. No financial incen-
tives were offered to participants during this study.
Participants were assured of their anonymity and all data
obtained were kept confidential.
Results
Characteristics of participants
In the present study, a total of 149 patients diagnosed
with psoriasis were approached and completed the ques-
tionnaire. The sociodemographic details of the study
patients are shown in Table 1. More than half (53%) of
the participants were below 40 years old. About 81
(54.4%) used medicinal plants instead of chemotherapy
while the rest of 68 (45.6%) did not used medicinal
plants instead of chemotherapy.
When the sociodemographic variables of users and
nonusers of medicinal plants were compared, character-
istics like age and household income were significantly
associated as shown by the χ2 or Fisher’s exact tests and
Spearman’s correlation coefficients (Table 2). There was
a significant low correlation between the marital status
and use of medicinal plants as shown in Table 2.
Medicinal plants used
In this study, 81 patient with psoriasis declared that they
used at least one medicinal plant in the last 6 months to
treat signs/symptoms of their psoriasis. The majority of
these patients used more than one medicinal plant
concurrently.
All patients with psoriasis who participated in this
study declared that they used Aloe vera. The second
most commonly used medicinal herb was Trigonella
arabica which was reported by 65 (80.2%) patients
followed by Catharanthus roseus which was reported by
60 (74.1%) and Anthemis cotula which was reported by
28 (71.6%). A detailed list of the medicinal plants
reported in this study are shown in Table 3.
Leaves and fruits were the most commonly used parts
of the medicinal plants. The rest of parts used by the
study patients are shown in Table 3. Medicinal plants
were most frequently prepared in the form of pastes
(Table 3). Medicinal plants were obtained from different
sources. The majority of the patients obtained their me-
dicinal plants from wild life (Table 4). When asked about
their source of knowledge on medicinal plants, the
majority of the study participants stated that medicinal
plants were recommended by other patients with
psoriasis (Table 4).
Reasons for using or not using medicinal plants
When asked why they use medicinal plants to manage their
psoriasis, patients using medicinal plants gave various rea-
sons. The most commonly reported reason was safety.
Other reasons reported in this study are shown in Table 4.
When nonusers were asked why they were not using
medicinal plants to manage their psoriasis, again they
mentioned many reasons of which concerns over safety
was the most frequently reported reason. Other reasons
are shown in Table 4.
Discussion
This is the first investigation on the use of medicinal
plants in patients with psoriasis in Palestine. The find-
ings from this study showed that 54.4% of the patients
included in this study used medicinal plants to treat
signs/symptoms of their psoriasis. Our results were con-
sistent with prior studies in which the prevalence of
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CAM use was in the range of 43–69% in different coun-
tries including the US, UK and Taiwan [15, 20–22].
Comparisons using χ2 or Fisher’s exact analyses showed
that users of medicinal plants differed with regard to age
and monthly household income. However, educational
level, place of residence, stage of the disease and time re-
lapsed since diagnosis were not significantly associated
with the use of medicinal plants. Nonparametric correl-
ation showed that age and marital status were significantly
and positively correlated with the use of medicinal plants.
However, monthly household income was significantly
and negatively correlated with the use of medicinal plants.
In this study, the most commonly reason for using medi-
cinal plants was the belief that these CAM modalities
were safe (27.5%). Patients also reported enhancing im-
munity and reducing side effects of conventional therapies
(16.7%). These results were in line with those reported in
the UK in which dissatisfaction with the results of conven-
tional therapies was the most commonly reported reason
for using CAM modalities (including the use of medicinal
plants) by patients with psoriasis [23].
This study showed that 33 different plants were used
with various methods of preparation by patients to treat
their psoriasis. The most commonly used plants were
Aloe vera, Trigonella arabica, Catharanthus roseus and
Anthemis cotula. Some results were not surprising as
Aloe vera was reported to be commonly used by patients
with psoriasis in prior studies [15, 17, 24, 25]. Random-
ized clinical trials were conducted using a cream
containing Aloe vera in patients with psoriasis which
showed statistically significant improvements [24]. Pro-
gressive reduction of lesions, desquamation, decreased
erythema, infiltration, lower psoriasis area and severity
index score (PASI) were considered as improvements
[24]. PASI scores in the treatment group decreased from
9.7 to 2.2 compared to 8.9 to 8.2 in the placebo-
controlled group [24]. Untoward effects were not
reported in this study. Paulsen et al. used a gel contain-
ing Aloe vera in a randomized placebo-controlled trails
[25]. Modified PASI scores decreased in 75.2% of
patients in the treatment group compared to placebo
group [25]. Probably, patients in our study witness











P value Correlation P value
Age (years)
< 40 79 53.0 26 53 31.2 <0.001 0.458 <0.01
≥ 40 70 47.0 55 15
Educational level
No formal education or primary
school
35 23.5 20 15 0.14 0.85 −0.031 0.7
Higher education 114 76.5 61 53
Monthly household income
Low 57 38.3 49 8 37.2 <0.001 −0.499 <0.001
High 92 61.7 32 60
Marital status
Single 44 29.5 18 26 4.6 0.1 0.169 0.04
Married 100 67.1 60 40
Other (divorced/widowed) 5 3.4 3 2
Place of residence
City 62 41.6 33 29 0.23 0.96 0.012 0.88
Village 79 53.0 44 35
Camp 8 5.4 4 4
Psoriasis stage
Early 51 34.2 25 26 0.89 0.22 0.077 0.35
Late 98 65.8 56 42
Period relapsed since diagnosis (years)
< 2 70 47.0 37 33 0.12 0.73 0.028 0.73
≥ 2 79 53.0 44 35
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improvements from using Aloe vera based preparations
and spread the word to family, friends and other
patients. Interestingly in this study, a significant number
of patients with psoriasis learned about medicinal plants
from family friends and other patients with psoriasis.
Many of the plants reported by the patients in this
study were used for their promised activity against psor-
iasis [26]. The rhizomes of Curcuma longa has been in
use in traditional medicine since thousands of years to
treat various inflammatory disorders including psoriasis
[26]. The main constituent in Curcuma longa is curcu-
min to which anti-psoriatic activities are attributed. It is
thought that curcumin targets various transcription fac-
tors such as NF-KB, AP-1 and PPARγ, enzymes such as
COX2, 5-LOX, iNOS and hemeoxygenase- 1, cell cycle
proteins such as cyclin D1 and p21, cytokines like TNF,
IL-1, IL-6 and some cell surface adhesion molecules
[26–28]. Zingiber officinale is also thought to exhibit
anti-psoriatic activity though 6-Gingerol which is a nat-
ural analogue of curcumin [29]. Glycyrrhiza glabra was
shown to possess anti-proliferative and anti-inflammatory
activities in psoriasis [30]. The use of Glycyrrhiza glabra
was reported to be safe, effective and inexpensive [26, 30].
Some of the medicinal plants used by the patients who
participated in this study were not previously reported
to be used to treat psoriasis. These plants include Trigo-
nella arabica. However, other members of the same
leguminosae family like Psoralea corylifolia L. were
shown to contain phenolic glycosides which might
inhibit keratinocytes replication in psoriasis [31]. Crota-
laria emarginella Vatke is another member of the same
family was shown to contain crotalic acid which exhib-
ited anti-inflammatory action in psoriasis [26].
Interestingly, many of the medicinal plants reported to
be used in this study are edible and widely used in folk
diet. This might suggest that these plants could be
nontoxic or possess low toxic activities. However, it is im-
portant not to overestimate the safety and efficacy of the
medicinal plants reported to be used in ethnopharmacolo-
gical surveys. Prior studies showed that some of the medi-
cinal plants used were associated with unwanted side
effects. For example, some Trigonella arabica species were
reported to have hypoglycemic effect when used systemic-
ally [32]. However, it is noteworthy to mention that topical
application on the skin is often associated with less severe
side effects than systemic exposure.
It is also important to note that the efficacy of some
treatments were questionable as randomized clinical trials
failed to demonstrate significant improvements in psoria-
sis patients [15, 17]. For example, Stucker et al. treated 13
patients with psoriasis topically with a combination of
vitamin B12 and avocado oil, after 12 weeks no statistically
significant reduction in PASI scores was observed [33].
As Aloe vera, Trigonella arabica, Catharanthus roseus
and Anthemis cotula were the most frequently used
medicinal plants by patients with psoriasis who partici-
pated in this study, a brief review of their uses, side
effects, in vivo and in vitro activity in psoriasis are briefly
reviewed and summarized in Table 5.
In the present study, the majority of the medicinal
plants were prepared in the form of pastes. Pastes were
most commonly prepared from leaves and fruits. This
was consistent with the nature of the disease and the
intended action as agents were meant to be applied
Table 4 Sources, knowledge and reasons for using or not using
medicinal plants
Item Percent







Sources from where patients obtained








Reason reported by patients for using
medicinal plants
Medicinal plants enhance my immune
system
16.7
I was advised to use medicinal plants 15.8
Medicinal plants are available and
affordable
5
Using medicinal plants is safe 27.5
Medicinal plants are effective 11.7
I have sufficient experience and
information about medicinal plants
6.67
Medicinal plants improve conventional
therapy and reduce their side effects
16.7
Reason reported by patients for not using
medicinal plants
I don’t have enough information on
medicinal plants
28
I am not convinced that medicinal
plants are better than conventional
therapies
16
Medicinal plants might have serious
side effects
56
Shawahna and Jaradat BMC Complementary and Alternative Medicine  (2017) 17:4 Page 7 of 9
topically. Taken together, a considerable percentage of
patients who used medicinal plants believed in their
safety and therapeutic power. This was consistent with
our recent study in which patients with cancer who used
medicinal plants believed in their power to treat breast
cancer in the West Bank [13].
Conclusions
The prevalence of use of medicinal plants among psoriasis
patients in Palestine was not known. This study showed
that the use of medicinal plants was prevalent among
patients with psoriasis in Palestine. This ethnopharmaco-
logical survey showed that Aloe vera, Trigonella arabica,
Catharanthus roseus and Anthemis cotula were the most
frequently used medicinal plants to treat psoriasis. The
use of medicinal plants was associated with age and
household income of the patients. The majority of the
patients using medicinal plants believed in their power of
treatment and safety. More randomized clinical trials are
needed to demonstrate the efficacy and safety of these
medicinal plants in patients with psoriasis.
Additional file
Additional file 1: Interviewer administered survey of medicinal plants
use by psoriasis patients in the West Bank of Palestine. (DOCX 18 kb)
Abbreviations
CAM: Complementary and alternative medicine; IRB: Institutional Review
Board; PASI: Psoriasis area and severity index
Acknowledgement
Authors would like to thank Mais Asmah for her technical help with data entry.
Funding
This study did not receive any specific funds.
Availability of data and materials
The questionnaire used in this study is provided in the supplementary materials.
Authors’ contributions
RS and NAJ designed the study, performed data acquisition and analysis and
drafted the manuscript. All authors read and approved the final manuscript
for submission.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
This study was ethically approved by the Institutional Review Board (IRB) of
An-Najah National University (protocol #62/Aug/2015). All study participants
gave consent before taking part in the study.
Author details
1Department of Physiology and Pharmacology, Faculty of Medicine and
Health Sciences, An-Najah National University, New Campus, Building: 19,
Office: 1340, PO Box 7, Nablus, Palestine. 2An-Najah BioSciences Unit, Center
for Poisons Control, Chemical and Biological Analyses, An-Najah National
University, Nablus, Palestine. 3Department of Pharmacy, Faculty of Medicine
and Health Sciences, An-Najah National University, Nablus, Palestine.
Received: 19 April 2016 Accepted: 8 December 2016
References
1. Tse WP, Che CT, Liu K, Lin ZX. Evaluation of the anti-proliferative properties
of selected psoriasis-treating Chinese medicines on cultured HaCaT cells.
J Ethnopharmacol. 2006;108(1):133–41.
Table 5 Summary of published ethnopharmacological uses, side effects, in vivo and in vitro activity of the most frequently used
plants against psoriasis
Plant species Reported ethnopharmacological
use with reference source
In vivo and in vitro activity against
psoriasis with reference source
Side effects and toxicity with reference
source
Aloe vera The plant was used in folk medicine for
the treatment of psoriasis in South Africa
[34], Turkey [35], Pakistan [36], India [37],
Middle East [38], Palestine [17, 39] and
Mexico [40].
Hydrophilic cream and gel of Aloe vera
were tried and showed significant
improvement against psoriasis in a
randomized clinical trial [24, 25]. In
another study, topical Aloe vera with
0.1% triamcinolone acetonide was
used in mild to moderate plaque
psoriasis. Aloe showed its ability to
reduce the clinical symptoms
of psoriasis [41].
Aloe extract showed anti-psoriatic
activity of 81.95%, compared with 87.94
for tazarotene in the mouse tail model
of psoriasis [42].
Localized side effects including dryness,
stinging, soreness, fissures, erythema and
contact urticaria may develop after using
topical Aloe [25, 43, 44].
Trigonella arabica The plant was used in ethnomedicine
for treatment of psoriasis in Palestine
[45] and Pakistan [46].
No reference No reference
Catharanthus roseus No reference C. roseus reduced the expression of
psoriatic marker, keratin 17 (K17) in
human keratinocytes [47].
No reference
Anthemis cotula No reference No reference Contact sensitization [48].
Shawahna and Jaradat BMC Complementary and Alternative Medicine  (2017) 17:4 Page 8 of 9
2. Nickoloff BJ, Nestle FO. Recent insights into the immunopathogenesis of
psoriasis provide new therapeutic opportunities. J Clin Invest.
2004;113(12):1664–75.
3. Ammar-Khodja A, Benkaidali I, Bouadjar B, Serradj A, Titi A, Benchikhi H,
Amal S, Hassam B, Sekkat A, Mernissi FZ, et al. EPIMAG: International Cross-
Sectional Epidemiological Psoriasis Study in the Maghreb. Dermatology.
2015;231(2):134–44.
4. Fleischer Jr AB, Feldman SR, Rapp SR, Reboussin DM, Exum ML, Clark AR,
Rajashekhar V. Disease severity measures in a population of psoriasis
patients: the symptoms of psoriasis correlate with self-administered psoriasis
area severity index scores. J Invest Dermatol. 1996;107(1):26–9.
5. Callen JP, Krueger GG, Lebwohl M, McBurney EI, Mease P, Menter A, Paller
AS, Pariser DM, Weinblatt M, Zimmerman G, et al. AAD consensus statement
on psoriasis therapies. J Am Acad Dermatol. 2003;49(5):897–9.
6. Rich SJ, Bello-Quintero CE. Advancements in the treatment of psoriasis: role
of biologic agents. J Manag Care Pharm. 2004;10(4):318–25.
7. Beyer V, Wolverton SE. Recent trends in systemic psoriasis treatment costs.
Arch Dermatol. 2010;146(1):46–54.
8. Horn EJ, Fox KM, Patel V, Chiou CF, Dann F, Lebwohl M. Are patients with
psoriasis undertreated? Results of National Psoriasis Foundation survey.
J Am Acad Dermatol. 2007;57(6):957–62.
9. Patel V, Horn EJ, Lobosco SJ, Fox KM, Stevens SR, Lebwohl M. Psoriasis
treatment patterns: results of a cross-sectional survey of dermatologists.
J Am Acad Dermatol. 2008;58(6):964–9.
10. Zaghloul SS, Goodfield MJ. Objective assessment of compliance with
psoriasis treatment. Arch Dermatol. 2004;140(4):408–14.
11. Lebwohl M, Ali S. Treatment of psoriasis. Part 2. Systemic therapies.
J Am Acad Dermatol. 2001;45(5):649–61. quiz 62–4.
12. Griffiths CE, Richards HL. Psychological influences in psoriasis. Clin Exp
Dermatol. 2001;26(4):338–42.
13. Jaradat NA, Shawahna R, Eid AM, Al-Ramahi R, Asma MK, Zaid AN. Herbal
remedies use by breast cancer patients in the West Bank of Palestine.
J Ethnopharmacol. 2016;178:1–8.
14. Dalaker M, Jacobsen T, Lysvand H, Iversen OJ. Expression of the psoriasis-
associated antigen, Pso p27, is inhibited by cyclosporin A. Acta Derm
Venereol. 1999;79(4):281–4.
15. Smith N, Weymann A, Tausk FA, Gelfand JM. Complementary and
alternative medicine for psoriasis: a qualitative review of the clinical trial
literature. J Am Acad Dermatol. 2009;61(5):841–56.
16. Damevska K, Neloska L, Nikolovska S, Gocev G, Duma S. Complementary
and alternative medicine use among patients with psoriasis. Dermatol Ther.
2014;27(5):281–3.
17. Ben-Arye E, Ziv M, Frenkel M, Lavi I, Rosenman D. Complementary medicine
and psoriasis: linking the patient’s outlook with evidence-based medicine.
Dermatology. 2003;207(3):302–7.
18. Bauml JM, Chokshi S, Schapira MM, Im EO, Li SQ, Langer CJ, Ibrahim SA,
Mao JJ. Do attitudes and beliefs regarding complementary and alternative
medicine impact its use among patients with cancer? A cross-sectional
survey. Cancer. 2015;121(14):2431–8.
19. Bauml J, Langer CJ, Evans T, Garland SN, Desai K, Mao JJ. Does perceived
control predict Complementary and Alternative Medicine (CAM) use among
patients with lung cancer? A cross-sectional survey. Support Care Cancer.
2014;22(9):2465–72.
20. Fleischer Jr AB, Feldman SR, Rapp SR, Reboussin DM, Exum ML, Clark AR.
Alternative therapies commonly used within a population of patients with
psoriasis. Cutis. 1996;58(3):216–20.
21. Baron SE, Goodwin RG, Nicolau N, Blackford S, Goulden V. Use of
complementary medicine among outpatients with dermatologic conditions
within Yorkshire and South Wales, United Kingdom. J Am Acad Dermatol.
2005;52(4):589–94.
22. Chen YF, Chang JS. Complementary and alternative medicine use among
patients attending a hospital dermatology clinic in Taiwan. Int J Dermatol.
2003;42(8):616–21.
23. Clark CM, McKay RA, Fortune DG, Griffiths CE. Use of alternative treatments
by patients with psoriasis. Br J Gen Pract. 1998;48(437):1873–4.
24. Syed TA, Ahmad SA, Holt AH, Ahmad SA, Ahmad SH, Afzal M. Management
of psoriasis with Aloe vera extract in a hydrophilic cream: a placebo-
controlled, double-blind study. Trop Med Int Health. 1996;1(4):505–9.
25. Paulsen E, Korsholm L, Brandrup F. A double-blind, placebo-controlled study
of a commercial Aloe vera gel in the treatment of slight to moderate
psoriasis vulgaris. J Eur Acad Dermatol Venereol. 2005;19(3):326–31.
26. Rahman M, Alam K, Ahmad MZ, Gupta G, Afzal M, Akhter S, Kazmi I, Jyoti,
Ahmad FJ, Anwar F. Classical to current approach for treatment of psoriasis:
a review. Endocr Metab Immune Disord Drug Targets. 2012;12(3):287–302.
27. Matsuda H, Tewtrakul S, Morikawa T, Nakamura A, Yoshikawa M. Anti-
allergic principles from Thai zedoary: structural requirements of
curcuminoids for inhibition of degranulation and effect on the release of
TNF-alpha and IL-4 in RBL-2H3 cells. Bioorg Med Chem. 2004;12(22):5891–8.
28. Heng MC, Song MK, Harker J, Heng MK. Drug-induced suppression of
phosphorylase kinase activity correlates with resolution of psoriasis as
assessed by clinical, histological and immunohistochemical parameters.
Br J Dermatol. 2000;143(5):937–49.
29. Kim SO, Kundu JK, Shin YK, Park JH, Cho MH, Kim TY, Surh YJ. [6]-Gingerol
inhibits COX-2 expression by blocking the activation of p38 MAP kinase and
NF-kappaB in phorbol ester-stimulated mouse skin. Oncogene.
2005;24(15):2558–67.
30. Man MQ, Shi Y, Man M, Lee SH, Demerjian M, Chang S, Feingold KR, Elias
PM. Chinese herbal medicine (Tuhuai extract) exhibits topical anti-
proliferative and anti-inflammatory activity in murine disease models.
Exp Dermatol. 2008;17(8):681–7.
31. Sampson JH, Raman A, Karlsen G, Navsaria H, Leigh IM. In vitro keratinocyte
antiproliferant effect of Centella asiatica extract and triterpenoid saponins.
Phytomedicine. 2001;8(3):230–5.
32. Puri D, Prabhu K, Murthy P. Mechanism of action of a hypoglycemic
principle isolated from fenugreek seeds. Indian J Physiol Pharmacol.
2002;46(4):457–62.
33. Stucker M, Memmel U, Hoffmann M, Hartung J, Altmeyer P. Vitamin B(12)
cream containing avocado oil in the therapy of plaque psoriasis.
Dermatology. 2001;203(2):141–7.
34. Mabona U, Viljoen A, Shikanga E, Marston A, Van Vuuren S. Antimicrobial activity
of southern African medicinal plants with dermatological relevance: from an
ethnopharmacological screening approach, to combination studies and the
isolation of a bioactive compound. J Ethnopharmacol. 2013;148(1):45–55.
35. Keseroglu H, Gönül M, Kurmus G. Prevalence of herbal therapy usage in
patients with psoriasis in Turkey. TANG. 2015;5(2):48–52.
36. Jamal Z, Ahmad MZ, Zafar M, Sultana S, Khan M, Shah G. Medicinal plants
used in traditional folk recipes by the local communities of Kaghan valley,
Mansehra, Pakistan. Indian J Tradit Know. 2012;11:634–9.
37. Rajeswari R, Umadevi M, Rahale C, Pushpa R, Selvavenkadesh S, Kumar K,
Bhowmik D. Aloe vera: the miracle plant its medicinal and traditional uses
in India. J Pharmacogn Phytochem. 2012;1(4):118–24.
38. Oumeish Y. Traditional Arabic medicine in dermatology. Clin Dermatol.
1999;17(1):13–20.
39. Jaradat NA. Ethnopharmacological survey of natural products in palestine.
An-Najah Univ J Res. 2005;19:13–67.
40. Rodriguez-Fragoso L, Reyes-Esparza J, Burchiel S, Herrera-Ruiz D, Torres E.
Risks and benefits of commonly used herbal medicines in Mexico. Toxicol
Appl Pharmacol. 2008;227(1):125–35.
41. Choonhakarn C, Busaracome P, Sripanidkulchai B, Sarakarn P. A prospective,
randomized clinical trial comparing topical aloe vera with 0.1%
triamcinolone acetonide in mild to moderate plaque psoriasis. J Eur Acad
Dermatol Venereol. 2010;24(2):168–72.
42. Dhanabal S, Priyanka Dwarampudi L, Muruganantham N, Vadivelan R.
Evaluation of the antipsoriatic activity of Aloe vera leaf extract using a
mouse tail model of psoriasis. Phytother Res. 2012;26(4):617–9.
43. Morrow D, Rapaport M, Strick R. Hypersensitivity to aloe. Arch Dermatol.
1980;116(9):1064–5.
44. Graf J. Herbal anti-inflammatory agents for skin disease. Skin Therapy Lett.
2000;5(4):3–5.
45. Jaradat NA. Medical plants utilized in Palestinian folk medicine for treatment
of diabetes mellitus and cardiac diseases. J Al-Aqsa Unv. 2005;9:1–28.
46. Huma A, Rizwani G, Usman M, Ishaque S, Ansari S, Anwer S. Drug
development of herbomineral capsule (ALG-06) used for hypopigmentation
specially in vitiligo. Pak J Pharm Sci. 2014;27(5 Spec No):1451–7.
47. Pattarachotanant N, Rakkhitawatthana V, Tencomnao T. Effect of Gloriosa
superba and Catharanthus roseus Extracts on IFN-γ-Induced Keratin 17
Expression in HaCaT Human Keratinocytes. Evid Based Complement Alternat
Med. 2014;2014:249367.
48. Paulsen E. Contact sensitization from Compositae-containing herbal
remedies and cosmetics. Contact Dermatitis. 2002;47(4):189–98.
Shawahna and Jaradat BMC Complementary and Alternative Medicine  (2017) 17:4 Page 9 of 9
